Edition:
United States

Dova Pharmaceuticals Inc (DOVA.OQ)

DOVA.OQ on NASDAQ Stock Exchange Global Market

30.13USD
2:31pm EST
Change (% chg)

$0.05 (+0.17%)
Prev Close
$30.08
Open
$30.80
Day's High
$30.95
Day's Low
$30.12
Volume
21,072
Avg. Vol
37,803
52-wk High
$31.56
52-wk Low
$16.98

Select another date:

Mon, Nov 27 2017

BRIEF-Dova Pharmaceuticals Announces FDA Acceptance Of The Avatrombopag New Drug Application With Priority Review

* DOVA PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF THE AVATROMBOPAG NEW DRUG APPLICATION (NDA) WITH PRIORITY REVIEW

BRIEF-Dova Pharmaceuticals reports third quarter results

* Dova Pharmaceuticals reports third quarter 2017 operating and financial results

BRIEF-Dova Pharmaceuticals announces New Drug Application submission to FDA

* Dova Pharmaceuticals announces New Drug Application submission to FDA for avatrombopag, a second generation thrombopoietin receptor agonist

BRIEF-Dova Pharmaceuticals qtrly net loss per share, basic and diluted $0.32

* Dova Pharmaceuticals reports second quarter 2017 operating and financial results

BRIEF-Perceptive Advisors reports 6.8 pct passive stake in Dova Pharma

* Perceptive Advisors Llc reports a 6.8 pct passive stake in Dova Pharmaceuticals Inc as of July 5 - SEC filing Source text: (http://bit.ly/2uQUtT6)

BRIEF-Dova Pharma sees IPO to be priced between $15 and $17/shr

* Dova Pharmaceuticals Inc sees IPO of upto 4.06 million shares of common stock to be priced between $15 and $17 per share - SEC filing

Select another date: